Search

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Read More

Literati Special - Meet The Author: Ben Mezrich

Location: PlayroomTime: 12:30PM - 1:30PMWith a…
Read More

Art Reception - "It's a little personal"

Location: CafeTime: 4:30PM - 7PM"What's Between…
Read More

Resident Company Profile: Angiex

We’re excited to launch a new blog series…
Read More

Quench Bio emerges with $50M to treat severe inflammatory diseases

Read More

LabCentral’s Measures in Response to COVID-19 for Our Community

Disclaimer: The views, thoughts, and opinions…
Read More

LabCentral’s COVID-19 Update for Our Community

As the quickly-developing COVID-19 crisis…
Read More

Our Response to the Massachusetts Essential Services Order

Like you, the LabCentral team is actively…
Read More

LabCentral Virtual Event Series: Innovation and Biotech in the Time of COVID-19

Disclaimer: the views, thoughts, and opinions…
Read More

COVID-19 Updates: Close Contact Rules, Face Masks and Virtual Events

We’d like to thank our community for their…
Read More